No. of Pages: 183 | Report Code: BMIRE00028086 | Category: Life Sciences
因院内感染增加而导致败血症的高发病率中美洲脓毒症诊断市场增长
感染是脓毒症的根本原因。脓毒症主要发生在免疫功能低下的人群中，例如接受化疗、接受脾切除手术、患有艾滋病和糖尿病等慢性疾病的人。在多种感染类型中，医院感染是住院患者发病和死亡的主要原因。大多数死亡可以通过早期诊断和适当的临床管理来预防。这些死亡通常是腹泻病或下呼吸道感染的结果。因此，脓毒症的高发病率预计将增加对脓毒症诊断产品的需求，从而支持南美和南亚地区。预测期内中美洲败血症诊断市场的增长。
South &中美洲脓毒症诊断市场概况
南部和南部地区中美洲败血症诊断市场分为阿根廷、巴西和南美其他地区。中美洲。该地区的市场增长归因于该地区人口老龄化的加剧和败血症病例负担的增加。
南&中美洲脓毒症诊断市场细分
南部和中部地区中美洲脓毒症诊断市场根据产品、技术、方法、测试类型、病原体、最终用户和国家进行细分。
根据产品，南方&中美洲脓毒症诊断市场分为仪器、试剂和测定、血液培养基和软件。 2021年，血液培养基细分市场占据最大市场份额。
以技术为基础，南方&;中美洲脓毒症诊断市场细分为分子诊断、流式细胞术、微流体、免疫分析、生物标志物和微生物学。微生物学领域在2021年占据最大的市场份额。分子诊断领域的市场细分为聚合酶链反应、肽核酸荧光原位杂交、基于综合征的检测和微阵列。
根据方法，South &中美洲脓毒症诊断市场分为自动诊断和传统诊断。传统诊断领域在 2021 年占据了更大的市场份额。
根据测试类型，South &中美洲脓毒症诊断市场分为现场护理测试和实验室测试。实验室检测领域在 2021 年占据了更大的市场份额。
根据病原体，南部和南部地区中美洲脓毒症诊断市场分为细菌脓毒症、真菌脓毒症等。细菌性败血症细分市场在 2021 年占据最大的市场份额。
根据最终用户，南部和南部地区中美洲脓毒症诊断市场分为医院、病理学和参考实验室等。 2021 年，医院细分市场占据最大的市场份额。
按国家/地区划分，南部和非洲地区。中美洲脓毒症诊断市场分为巴西、阿根廷和南美洲其他地区。中美洲。巴西在 2021 年占据主导地位。
Abbott; BD;生物梅里埃公司；丹纳赫（贝克曼库尔特）； F. 霍夫曼拉罗什有限公司；和 THERMO FISHER SCIENTIFIC INC. 是在南部和南部地区运营的领先公司之一。中美洲败血症诊断市场。
Strategic insights for South & Central America Sepsis Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 38.66 Million |
| Market Size by 2028 | US$ 69.59 Million |
| Global CAGR (2021 - 2028) | 8.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South & Central America Sepsis Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Sepsis Diagnostics Market is valued at US$ 38.66 Million in 2021, it is projected to reach US$ 69.59 Million by 2028.
As per our report South & Central America Sepsis Diagnostics Market, the market size is valued at US$ 38.66 Million in 2021, projecting it to reach US$ 69.59 Million by 2028. This translates to a CAGR of approximately 8.8% during the forecast period.
The South & Central America Sepsis Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Sepsis Diagnostics Market report:
The South & Central America Sepsis Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Sepsis Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Sepsis Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Sepsis Diagnostics Market
